Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC |
Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS |
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 02.05. FARMACOS FIBRINOLITICOS | No observations |
| List | Section | Observation |
|---|---|---|
| PAHO Strategic Fund Medicine List | 6.3. Antithrombotic medicines |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| Peru | 12.5 Anti-Thrombotics | No observations |
| Ecuador | Essential Medicines List - Ecuador | No observations |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 11. Agentes anticoagulantes, trombolíticos y antiplaquetarios | No observations |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 01.12 FIBRINOLYTIC | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 03. CARDIOLOGIA | No observations |
| Paraguay. Lista de Medicamentos Esenciales. 2009 | 01. AGENTES ANTITROMBÓTICOS | No observations |
| El Salvador - 2019 | AGENTES ANTITROMBÓTICOS | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 11.05. MEDICAMENTOS ANTITROMBOTICOS Y USADOS EN EL INFARTO AL MIOCARDIO | No observations |
| WHO Model List of Essential Medicines (2021) | 12.5.2 Thrombolytic medicines | No observations |
| Guyana. Essential Medicines List. 2020-2021 | 12.03. Fibrinolytic | No observations |
| Suriname. NGK-C-011 | 12.5 Anti-Thrombotics and Thrombolytics | No observations |
| Haiti. National List of Essential Medicines | 12.05.02 Thrombolytic drugs (see supplementary list) | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 20.12.20 Thrombolytic Agents | No observations |
| Belize. National Drug Formulary | 12.05 Antithrombotic medicines | No observations |
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 02.10.01 Fibrinolytic Drugs | No observations |
| List | Section | Observation |
|---|---|---|
| Mexico. Cuadro Basico de Medicamentos - 2017 | 03. CARDIOLOGIA | No observations |
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | B. SANGUE E ÓRGÃOS HEMATOPOÉTICOS | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 11.05. MEDICAMENTOS ANTITROMBOTICOS Y USADOS EN EL INFARTO AL MIOCARDIO | No observations |
| List | Section | Observation |
|---|---|---|
| Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: BBO.(HEBERKINASA) |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 03. CARDIOLOGIA | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 11.05. MEDICAMENTOS ANTITROMBOTICOS Y USADOS EN EL INFARTO AL MIOCARDIO | No observations |
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 24:40 Thrombolytic agents | No observations |
| List | Section | Observation |
|---|---|---|
| Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: PROCTOKINASA, EST.X 4 |